# After Losing a Key Vaccine Contract to India at Triple the Price, South Africa Biovac Is Back with European Money - Date: 2026-04-17 - Category: Biotech & Life Sciences Three years after being undercut three-to-one on price by India Serum Institute and laying off 80 staff, Biovac has secured 75M EUR from the European Investment Bank and 20M USD from the World Bank to build Africa first end-to-end vaccine plant in Cape Town. ---